July 30, 2010 – A drug-eluting coronary bifurcation stent received CE mark this week for clinical use in Europe. The Axxess Biolimus A9-Eluting Coronary Bifurcation Stent System uses a bioabsorbable coating on a self-expanding stent made by Devax.
July 30, 2010 – An upgraded Holter monitoring system now features Windows 7 compatibility, improved Bluetooth functionality, advanced editing capabilities and multiple final report customization options. The upgrades to the Welch Allyn Holter System are designed to optimize clinician workflow for easier, faster and more efficient evaluations.
July 30, 2010 – The first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation (SCS), or neurostimulation, to improve clinical signs and symptoms of heart failure, began this week.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 30, 2010 – A cardiac patient remote monitoring solution that feeds live information to smart phones was cleared for use by the U.S. Food and Drug Administration (FDA). The software includes the AirStrip Remote Patient Monitoring solution (RPM), including AirStrip RPM Critical Care and AirStrip RPM Cardiology.
July 29, 2010 – A new, highly anticipated antiplatelet drug was recommended yesterday for final approval by the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee. The drug may challenge the current standard therapy of clopidogrel.
July, 29, 2010 – A second generation transradial compression bracelet is designed to obtain a stable compression of the radial artery. The Zoom 2010 Transradial Compression Bracelet device from Zoom Co Medic can be adjusted by tightening the knob to increase or decrease the pressure as needed.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 29, 2010 – To help physicians overcome the medical technology challenges that impede rapid adoption of connected medical technologies, Best Buy For Business and Cardiac Science Corp. recently announced an alliance.
July 28, 2010 – The Council on Radionuclides and Radiopharmaceuticals (CORAR) applauded a recent decision by a Medicare administrative to correct coding, coverage and payment policies for radiopharmaceuticals used with myocardial perfusion imaging procedures.
July 28, 2010 – This week St. Jude Medical filed a patent infringement lawsuit against Volcano Corp. over its fractional flow reserve (FFR) wires. The suit was filed in federal district court in Delaware. Volcano said the claims against it are entirely without merit.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 27, 2010 – Two new cardiac stress test systems optimize space to allow testing in a greater variety of settings, offer wireless data acquisition and better electronic medical record (EMR) connectivity.
Heart failure is a progressively debilitating disease that dramatically decreases the life expectancy and quality of life of affected patients. Nearly 5.8 million Americans are diagnosed with heart failure today, according to annual American Heart Association statistics.
July 27, 2010 – Atherosclerotic plaque causes audible turbulence in the bloodstream and a new device can help isolate these sounds to aid in earlier detection of plaque changes.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 27, 2010 – Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based, guideline-recommended cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD) and drug therapy.
July 26, 2010 – Today a fourth-generation intracranial aneurysm stent system was released in both the U.S. and European markets. Boston Scientific’s Neuroform EZ Stent System is designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms.
July 26, 2010 – The U.S. Food and Drug Administration (FDA) approved the first generic version of Lovenox (enoxaparin sodium injection), an anticoagulant drug used for multiple indications, including prevention of deep vein thrombosis (DVT), a potentially deadly blood clotting condition.